About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 265868, 7 pages
http://dx.doi.org/10.1155/2012/265868
Research Article

Correlation of Circulating Glucocorticoid-Induced TNFR-Related Protein Ligand Levels with Disease Activity in Patients with Systemic Lupus Erythematosus

1Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China
2Department of Respiratory Disease, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China

Received 30 September 2012; Accepted 3 November 2012

Academic Editor: Pietro Invernizzi

Copyright © 2012 Lei Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Croker and R. P. Kimberly, “SLE: challenges and candidates in human disease,” Trends in Immunology, vol. 26, no. 11, pp. 580–586, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, “Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance,” Nature Immunology, vol. 3, no. 2, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. McHugh, M. J. Whitters, C. A. Piccirillo et al., “CD4+CD25+ Immunoregulatory T Cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor,” Immunity, vol. 16, no. 2, pp. 311–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ikeda, F. Takeshima, K. Ohba et al., “Flow cytometric analysis of expression of transforming growth factor-β and glucocorticoid-induced tumor necrosis factor receptor on CD4+ CD25+ T cells of patients with inflammatory bowel disease,” Digestive Diseases and Sciences, vol. 51, no. 1, pp. 178–184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Ronchetti, O. Zollo, S. Bruscoli et al., “Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations,” European Journal of Immunology, vol. 34, no. 3, pp. 613–622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Bae, W. J. Kim, Y. M. Kang et al., “Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis,” Clinical and Experimental Immunology, vol. 148, no. 3, pp. 410–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Nakae, H. Suto, G. J. Berry, and S. J. Galli, “Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice,” Blood, vol. 109, no. 9, pp. 3640–3648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Baltz, M. Krusch, T. Baessler et al., “Neutralization of tumor-derived soluble Glucocorticoid-Induced TNFR-related protein ligand increases NK cell anti-tumor reactivity,” Blood, vol. 112, no. 9, pp. 3735–3743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Chen, L. C. Ndhlovu, T. Takahashi et al., “Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells,” European Journal of Immunology, vol. 38, no. 8, pp. 2229–2240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. G. L. Stephens, R. S. McHugh, M. J. Whitters et al., “Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells,” Journal of Immunology, vol. 173, no. 8, pp. 5008–5020, 2004. View at Scopus
  11. I. D. Cardona, E. Goleva, L. S. Ou, and D. Y. M. Leung, “Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes,” Journal of Allergy and Clinical Immunology, vol. 117, no. 3, pp. 688–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Nocentini, S. Ronchetti, M. G. Petrillo, et al., “Pharmacological modulation of GITRL/GITR system: therapeutic perspectives,” British Journal of Pharmacology, vol. 165, no. 7, pp. 2089–2099, 2012.
  13. M. Azuma, “Role of the glucocorticoid-induced TNFR-related protein (GITR)-GITR ligand pathway in innate and adaptive immunity,” Critical Reviews in Immunology, vol. 30, no. 6, pp. 547–557, 2010. View at Scopus
  14. Y. Kamimura, H. Iwai, J. Piao, M. Hashiguchi, and M. Azuma, “The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity,” Journal of Immunology, vol. 182, no. 5, pp. 2708–2716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Avogadri, J. Yuan, A. Yang, D. Schaer, and J. D. Wolchok, “Modulation of CTLA-4 and GITR for cancer immunotherapy,” Current Topics in Microbiology and Immunology, vol. 344, pp. 211–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Burckhart, M. Thiel, H. Nishikawa et al., “Tumor-specific crosslinking of GITR as costimulation for immunotherapy,” Journal of Immunotherapy, vol. 33, no. 9, pp. 925–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Schaer, J. T. Murphy, and J. D. Wolchok, “Modulation of GITR for cancer immunotherapy,” Current Opinion in Immunology, vol. 24, no. 2, pp. 217–224, 2012.
  18. C. Buechele, T. Baessler, S. Wirths, et al., “Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL),” Leukemia, vol. 26, no. 5, pp. 991–1000, 2012.
  19. M. Patel, D. Xu, P. Kewin et al., “Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis,” European Journal of Immunology, vol. 35, no. 12, pp. 3581–3590, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Cuzzocrea, E. Ayroldi, R. Di Paola et al., “Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis,” The FASEB Journal, vol. 19, no. 10, pp. 1253–1265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Wang, Y. Shi, M. Yang, et al., “Glucocorticoid-induced tumor necrosis factor receptor family-related protein exacerbates collagen-induced arthritis by enhancing the expansion of Th17 cells,” The American Journal of Pathology, vol. 180, no. 3, pp. 1059–1067, 2012.
  22. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Scopus
  23. L. Z. Quan, C. Xie, T. Wu et al., “Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays,” Journal of Clinical Investigation, vol. 115, no. 12, pp. 3428–3439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Fehérvari and S. Sakaguchi, “Development and function of CD25+ CD4+ regulatory T cells,” Current Opinion in Immunology, vol. 16, no. 2, pp. 203–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Gavin and A. Rudensky, “Control of immune homeostasis by naturally arising regulatory CD4+ T cells,” Current Opinion in Immunology, vol. 15, no. 6, pp. 690–696, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Vasu, B. S. Prabhakar, and M. J. Holterman, “Targeted CTLA-4 engagement induces CD4+CD25+CTLA- 4high T regulatory cells with target (allo)antigen specificity,” Journal of Immunology, vol. 173, no. 4, pp. 2866–2876, 2004. View at Scopus
  27. A. Pedroza-Gonzalez, C. Verhoef, and J. N. Ijzermans, “Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer,” Hepatology. In press. View at Publisher · View at Google Scholar
  28. J. C. Crispin, A. Martínez, and J. Alcocer-Varela, “Quantification of regulatory T cells in patients with systemic lupus erythematosus,” Journal of Autoimmunity, vol. 21, no. 3, pp. 273–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Nocentini, S. Ronchetti, S. Cuzzocrea, and C. Riccardi, “GITR/GITRL: more than an effector T cell co-stimulatory system,” European Journal of Immunology, vol. 37, no. 5, pp. 1165–1169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, “Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance,” Nature Immunology, vol. 3, no. 2, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. L. T. Hiraki, S. M. Benseler, P. N. Tyrrell, D. Hebert, E. Harvey, and E. D. Silverman, “Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study,” The Journal of Pediatrics, vol. 152, no. 4, pp. 550–556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. La Cava, C. J. Fang, R. P. Singh, F. Ebling, and B. H. Hahn, “Manipulation of immune regulation in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 4, no. 8, pp. 515–519, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Benjamin, D. Sebastian, X. Cai, et al., “CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis,” Nephrology Dialysis Transplantation, vol. 24, no. 1, pp. 161–171, 2009. View at Publisher · View at Google Scholar · View at Scopus